Empagliflozin + Metformin Hydrochloride (জেনেরিক ওষুধ) সম্পর্কিত তথ্য

Indications: Indicated for the treatment of adults with Type 2 Dabetes Mellitus as an adjunct to diet and exercise.

Pharmacology: Emazid M 12.5/500 is a combination of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor and metformin hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate.Emazid M 12.5/500 is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. Howe...